These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 28911005)
1. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma. Wu D; Yang X; Peng H; Guo D; Zhao W; Zhao C; Zhou X Carcinogenesis; 2017 Sep; 38(9):910-919. PubMed ID: 28911005 [TBL] [Abstract][Full Text] [Related]
2. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
4. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling. Han S; Han L; Yao Y; Sun H; Zan X; Liu Q Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889 [TBL] [Abstract][Full Text] [Related]
5. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP). Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201 [TBL] [Abstract][Full Text] [Related]
6. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma. Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
8. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
9. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma. Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332 [TBL] [Abstract][Full Text] [Related]
10. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma]. Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213 [TBL] [Abstract][Full Text] [Related]
11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
12. Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing. Gao S; Yang Z; Zheng ZY; Yao J; Zhang F; Wu LM; Xie HY; Zhou L; Zheng SS World J Surg Oncol; 2013 Mar; 11():57. PubMed ID: 23496880 [TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma. Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994 [TBL] [Abstract][Full Text] [Related]
14. Krüppel‑like factor expression and correlation with FAK, MMP‑9 and E‑cadherin expression in hepatocellular carcinoma. Han S; Han L; Sun H; Zan X; Zhou Z; Xu K; Yao Y; Liu Q Mol Med Rep; 2013 Jul; 8(1):81-8. PubMed ID: 23670717 [TBL] [Abstract][Full Text] [Related]
15. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
16. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells. Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502 [TBL] [Abstract][Full Text] [Related]
18. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
19. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma. Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]